Customized Brain Stimulation to Help Finger Movement After Stroke
Tests AI-customized brain stimulation against sham stimulation for finger paralysis after stroke.
Key facts
- Who runs it
- NEUROPHET
- Where
- Seoul, South KoreaSee the site
- Trial code
- Registry title
- AI-based Customized tDCS for Finger Motor Recovery After Subacute Stroke
- Status
- Not yet recruiting
- People taking part
- 116 people, planned
- Started
- 30 Apr 2026
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- AI-based Customized transcranial Direct Current Stimulation
- Sham transcranial Direct Current Stimulation
- Record updated
- 24 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with finger and arm paralysis on one side after a stroke in the past 2 weeks to 3 months. It tests brain stimulation against a sham (no current) stimulation.
- Age
- 19 years or older
- Sex
- All sexes can join
- Disease stage
- Stroke confirmed by brain imaging, between 2 weeks and 3 months before. Paralysis of the upper limb on one side. Upper-extremity Fugl-Meyer Assessment (FMA-UE) score between 20 and 56 (maximum 66).
- Earlier treatment
- Cannot have used a similar stimulation device or joined a related clinical study in the past 1 year.
Main reasons for not taking part
- Cognitive problems or aphasia that prevent following instructions
- Delirium, confusion or other disorders of consciousness
- Uncontrolled epilepsy or uncontrolled medical or surgical conditions
- Cardiac pacemaker, cochlear implant, scalp disease or metal at the electrode site, or reasons that rule out MRI
- Pregnant or breastfeeding women, or women planning pregnancy during the study
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Participants must meet all of the following criteria to be eligible for this clinical trial:
- Adults aged 19 years or older
- Patients with stroke confirmed by brain imaging
- Subacute stroke patients within 2 weeks to 3 months after stroke onset
- Patients with unilateral upper-extremity paralysis
- Upper-extremity Fugl-Meyer Assessment (FMA-UE, maximum score 66) score between 20 and 56
- Participants who voluntarily provide written informed consent after receiving and understanding the study procedures and requirements
Who cannot take part
- Use of a stimulation device similar to the investigational device or participation in a related clinical study within the past 1 year
- History of a condition affecting the function of the paralyzed arm
- Inability to follow instructions or complete the study due to cognitive impairment or aphasia
- Evidence of delirium, confusion, or other disorders of consciousness
- Presence of uncontrolled medical or surgical conditions
- Severe neurological disorders associated with major psychiatric conditions (e.g., major depressive disorder, schizophrenia, bipolar disorder, or dementia)
- History of uncontrolled epilepsy (seizure disorder)
- Contraindications to transcranial direct current stimulation (tDCS), including:; Scalp disease or metal materials at the electrode attachment site; Presence of a cardiac pacemaker or cochlear implant
- Participants will be excluded if they meet any of the following criteria:
- Medical contraindications to MRI examination
- Pregnant or breastfeeding women, or those planning pregnancy during the study period
- Individuals judged by the investigator to be medically or ethically unsuitable for participation in this clinical study
Where in South Korea
- Severance hospitalSeoul, South KoreaContact: TaeYeong KimNot yet recruiting
About the trial
What the trial wants to find out
The goal of this clinical study is to evaluate whether AI-based customized transcranial direct current stimulation (tDCS) using MR images is more effective than sham stimulation in improving finger motor function in patients with finger paralysis caused by subacute stroke. The main questions it aims to answer are:
Read full original descriptionShow less
* Does AI-based customized tDCS improve finger motor function compared with sham stimulation? * What medical problems or adverse events occur when participants receive AI-based customized tDCS?
Researchers will compare AI-based customized tDCS with sham stimulation (a look-alike stimulation that delivers no electrical current) to determine whether the intervention improves finger motor recovery in patients with subacute stroke.
The 2 groups in the trial
- Experimental: AI-Based Customized tDCSTreatment being tested
Participants receive customized stimulation obtained from an individualized T1 MRI-based simulation of transcranial direct current stimulation for 30 minutes, once a day for 2 weeks, for a total of 10 sessions.
Treatment: AI-based Customized transcranial Direct Current Stimulation
- Sham Comparator: sham tDCSSham treatment, for comparison
Participants receive sham stimulation for 30 minutes once daily for 2 weeks (10 sessions total). Electrodes are placed according to the AI-based customized montage, but no current is delivered (0 mA).
Treatment: Sham transcranial Direct Current Stimulation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Multi-center, Randomized, Double-blind, Prospective, Superiority Clinical Trial to Evaluate the Safety and Effectiveness of Artificial Intelligence-based Customized Transcranial Direct Current Stimulation Using MR Images for Improving Finger Motor Function in Patients With Finger Paralysis Due to Subacute Stroke
- Plain-language title
- Customized Brain Stimulation to Help Finger Movement After StrokeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 24 March 2026